The molecular markers and therapeutic targets for early diagnosis of diabetic cardiomyopathy patients

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300073522

Enrollment

Unknown

Registered

2023-07-13

Start date

2023-07-12

Completion date

Unknown

Last updated

2023-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic cardiomyopathy

Interventions

Healthy volunteers:N/A

Type 2 diabetes without diastolic dysfunction:N/A

Diastolic dysfunction without type 2 diabetes:N/A

Type 2 diabetes mellitus with diastolic dysfunction:N/A

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Healthy volunteers; Type 2 diabetes without diastolic dysfunction; Diastolic dysfunction without type 2 diabetes; Type 2 diabetes mellitus with diastolic dysfunction; Type 2 diabetes mellitus and advanced DCM indicators such as systolic and diastolic dysfunction (heart transplantation required).

Exclusion criteria

Exclusion criteria: Patients with severe liver and kidney dysfunction, other endocrine system diseases, malignant tumors, and infectious diseases.

Design outcomes

Primary

Measure	Time frame
Serum molecular markers;	—

Countries

China

Contacts

Public ContactMa Haichun

The First Hospital of Jilin University

mahaichun2003@163.com+86 137 5691 5700

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026